Biden hints at executive actions on drug pricing 

The White House drug pricing plan released Thursday reiterates the administration’s enthusiasm for legislation empowering the government to negotiate drug prices, but the most important news is buried in sections describing options for executive action.

The white paper signals interest in taking actions that do not require legislation, such as streamlining requirements for developing biosimilars, using patent policy to incentivize innovation, and experimenting with new Medicare payment models. ...